Illumina, Inc. Logo

Illumina, Inc. (ILU)

FSX

Currency in EUR
186.12
+21.64 (+13.16%)

Real-time Data

06:00 AM

Day's Range

174.24
186.12

52 wk Range

75.83
186.12

Overview - ILU - Illumina, Inc.

Key Statistics

Valuation

Enterprise Value

25.40B

P/E (Trailing)

‪40.83‬

P/E (Forward)

‪37.41‬

PEG Ratio

‪-5.07‬

Price / Sales (TTM)

‪6.29‬

Price / Book

‪12.13‬

EV / EBITDA

‪25.68‬

Profitability

Profit Margin

‪18.33%‬

Operating Margin

‪21.13%‬

Return on Assets

‪8.66%‬

Return on Equity

‪32.33%‬

Ownership

Shares Outstanding

151.00M

Float

148.47M

Held by Insiders

‪0.19%‬

Held by Institutions

‪105.90%‬

Price stats

Beta

‪1.46‬

50-Day Avg

‪162.66‬

200-Day Avg

‪126.68‬

Dividends

Payout Ratio

‪0.00%‬

Peers - ILU - Illumina, Inc.

Peer Comparison

Compared with companies in Diagnostics & Research listed on FSX.

Profile Summary - ILU - Illumina, Inc.

About

Illumina, Inc. is a life sciences and diagnostics company that develops, manufactures, and markets tools and integrated systems for the analysis of genetic material. Its primary focus is on next-generation sequencing technologies, providing high-throughput and lower-throughput sequencing instruments, consumables, and…

SectorHealthcare
IndustryDiagnostics & Research
Employees8.60K
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Stocks news

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.